Versarien has announced that the signing of an agreement to develop a range of graphene-based sensor technologies to enable the creation of digital bandages and wound dressings capable of various forms of physiological movement and excretion detection.
This project will utilize strain sensors printed with graphene ink using methods which have been developed by the Company’s subsidiary, Cambridge Graphene Limited. Trials will take place at the internationally renowned Addenbrooke’s Hospital in Cambridge. The team will work to optimize the usability of the data from the graphene dressings to ensure the optimal recovery of the patients post discharge. The agreement will also involve Dr. Chris Crockford, Managing Director of Digital and Future Technologies Limited, who will act as liaison between the hospital, Versarien and wider global providers in this field.
In January 2018, Versarien noted the strong performances by British Skeleton World Cup competitor Dominic Parsons utilizing graphene-enhanced equipment provided by Versarien’s collaboration partner Bromley Technologies. In that same month, Versarien announced the signing of a Letter of Intent (LOI) to establish a graphene manufacturing center in China.